CAG repeat polymorphism of androgen receptor gene and X-chromosome inactivation in daughters of women with polycystic ovary syndrome (PCOS): Relationship with endocrine and metabolic parameters

Gynecological Endocrinology

Volumn 28, Issue 7, 2012, Pages 516-520

  Echiburú, Bárbara ^a   Pérez Bravo, Francisco ^b   Maliqueo, Manuel ^a   Ladrón De Guevara, Amanda ^a   Gálvez, Carla ^a   Crisosto, Nicolás ^a   Sir Petermann, Teresa ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

Author keywords

Androgen receptor; CAG repeat; PCOS; Polymorphisms

Indexed keywords

ANDROGEN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; SEX HORMONE;

ADOLESCENT; ANDROGEN RECEPTOR GENE; ARTICLE; CAG REPEAT; CHILD; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DNA POLYMORPHISM; ENDOCRINE DISEASE; FEMALE; GENE; HUMAN; INFANT; MAJOR CLINICAL STUDY; METABOLIC PARAMETERS; OVARY POLYCYSTIC DISEASE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEXUAL DEVELOPMENT; X CHROMOSOME INACTIVATION;

ADOLESCENT; ADOLESCENT DEVELOPMENT; ANDROGENS; CHILD; CHILD DEVELOPMENT; CHILD, PRESCHOOL; CHILE; CHOLESTEROL, HDL; FAMILY HEALTH; FEMALE; GENETIC ASSOCIATION STUDIES; HUMANS; INFANT; LEUKOCYTES; MOTHERS; POLYCYSTIC OVARY SYNDROME; POLYMORPHISM, GENETIC; RECEPTORS, ANDROGEN; TRINUCLEOTIDE REPEATS; X CHROMOSOME INACTIVATION;

EID: 84862863862     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2011.650744     Document Type: Article

References (30)

1. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol. Metab. 2004;89:2745-2749. (Pubitemid 38766360)
2. Franks S. Polycystic ovary syndrome. N Engl J Med 1995;333:853-861.
3. Ibanez L, Potau N, Marcos MV, De Zegher F. Exaggerated adrenarche and hyperinsulinism in adolescent girls born small for gestational age. J Clin Endocrinol. Metab. 1999;84:4739-4741.
4. Sir-Petermann T, Hitchsfeld C, Maliqueo M, Codner E, Echiburu B, Gazitua R, Recabarren S, Cassorla F. Birth weight in offspring of mothers with polycystic ovarian syndrome. Hum Reprod 2005;20:2122-2126. (Pubitemid 41418494)
5. Kahsar-Miller MD, Nixon C, Boots LR, Go RC, Azziz R. Prevalence of polycystic ovary syndrome (PCOS) in first-Degree relatives of patients with PCOS. Fertil Steril 2001;75:53-58. (Pubitemid 32042114)
6. Sir-Petermann T, Codner E, Perez V, Echiburu B, Maliqueo M, Ladron De Guevara A, Preisler J, et al. Metabolic and reproductive features before and during puberty in daughters of women with polycystic ovary syndrome. J Clin Endocrinol. Metab. 2009;94:1923-1930.
7. Mohlig M, Jurgens A, Spranger J, Hoffmann K, Weickert MO, Schlosser HW, Schill T, et al. The androgen receptor CAG repeat modifies the impact of testosterone on insulin resistance in women with polycystic ovary syndrome. Eur J Endocrinol 2006;155:127-130. (Pubitemid 44103380)
8. Luque-Ramirez M, San Millan JL, Escobar-Morreale HF. Genomic variants in polycystic ovary syndrome. Clin Chim Acta 2006;366:14-26. (Pubitemid 43330963)
9. Chamberlain NL, Driver ED, Miesfeld RL. The length and location of CAG trinucleotiDe repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res 1994;22:3181-3186. (Pubitemid 24260654)
10. Hickey T, Chandy A, Norman RJ. The androgen receptor CAG repeat polymorphism and X-chromosome inactivation in Australian Caucasian women with infertility related to polycystic ovary syndrome. J Clin Endocrinol. Metab. 2002;87:161-165. (Pubitemid 34084686)
11. Beilin J, Ball EM, Favaloro JM, Zajac JD. Effect of the androgen receptor CAG repeat polymorphism on transcriptional activity: specificity in prostate and non-prostate cell lines. J Mol Endocrinol 2000;25:85-96. (Pubitemid 30617076)
12. Wieacker PF, Knoke I, Jakubiczka S. Clinical and molecular aspects of androgen receptor Defects. Exp Clin Endocrinol Diabetes 1998;106:446-453. (Pubitemid 29015301)
13. Lappalainen S, Utriainen P, Kuulasmaa T, Voutilainen R, Jaaskelainen J. Androgen receptor gene CAG repeat polymorphism and X-chromosome inactivation in children with premature adrenarche. J Clin Endocrinol. Metab. 2008;93:1304-1309. (Pubitemid 351519725)
14. Li E. Chromatin modification and epigenetic reprogramming in mammalian Development. Nat Rev Genet 2002;3:662-673. (Pubitemid 34984255)
15. Matthews DR, Hosker JP, RuDenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis moDel assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419. (Pubitemid 15018832)
16. Calvo RM, Asuncion M, Sancho J, San Millan JL, Escobar-Morreale HF. The role of the CAG repeat polymorphism in the androgen receptor gene and of skewed X-chromosome inactivation, in the pathogenesis of hirsutism. J Clin Endocrinol. Metab. 2000;85:1735-1740. (Pubitemid 32289527)
17. Naumova AK, Plenge RM, Bird LM, Leppert M, Morgan K, Willard HF, Sapienza C. Heritability of X chromosome-inactivation phenotype in a large family. Am J Hum Genet 1996;58:1111-1119. (Pubitemid 26153821)
18. Jaaskelainen J, Korhonen S, Voutilainen R, Hippelainen M, Heinonen S. Androgen receptor gene CAG length polymorphism in women with polycystic ovary syndrome. Fertil Steril 2005;83:1724-1728. (Pubitemid 40824805)
19. Sir-Petermann T, Maliqueo M, Codner E, Echiburu B, Crisosto N, Perez V, Perez-Bravo F, Cassorla F. Early metabolic Derangements in daughters of women with polycystic ovary syndrome. J Clin Endocrinol. Metab. 2007;92:4637-4642. (Pubitemid 350223438)
20. Shah NA, Antoine HJ, Pall M, Taylor KD, Azziz R, Goodarzi MO. Association of androgen receptor CAG repeat polymorphism and polycystic ovary syndrome. J Clin Endocrinol. Metab. 2008;93:1939-1945. (Pubitemid 351656541)
21. Ibanez L, Ong KK, Mongan N, Jaaskelainen J, Marcos MV, Hughes IA, De Zegher F, Dunger DB. Androgen receptor gene CAG repeat polymorphism in the Development of ovarian hyperandrogenism. J Clin Endocrinol. Metab. 2003;88:3333-3338. (Pubitemid 36877513)
22. Vottero A, Capelletti M, Giuliodori S, Viani I, Ziveri M, Neri TM, Bernasconi S, Ghizzoni L. Decreased androgen receptor gene methylation in premature pubarche: a novel pathogenetic mechanism? J Clin Endocrinol. Metab. 2006;91:968-972. (Pubitemid 43357767)
23. Yen SSCJ, Chaney C, Judd HL. Functional aberrations of the hypothalamic pituitary system in polycystic ovary syndrome: a consiDeration of the pathogenesis. In: Serio M, editors. The endocrine function of the human ovary. New York: AcaDemic Press; 1976. pp 373-383.
24. Maliqueo M, Sir-Petermann T, Perez V, Echiburu B, De Guevara AL, Galvez C, Crisosto N, Azziz R. Adrenal function during childhood and puberty in daughters of women with polycystic ovary syndrome. J Clin Endocrinol. Metab. 2009;94:3282-3288.
25. Dasgupta S, Sirisha PV, Neelaveni K, Anuradha K, Reddy AG, Thangaraj K, Reddy BM. Androgen receptor CAG repeat polymorphism and epigenetic influence among the south Indian women with Polycystic Ovary Syndrome. PLoS ONE 2010;5:e12401.
26. Liu Q, Hong J, Cui B, Zhang Y, Gu W, Chi Z, Su Y, Ning G. Androgen receptor gene CAG(n) trinucleotiDe repeats polymorphism in Chinese women with polycystic ovary syndrome. Endocrine 2008;33: 165-170.
27. Hersberger M, Muntwyler J, Funke H, Marti-Jaun J, Schulte H, Assmann G, Luscher TF, von Eckardstein A. The CAG repeat polymorphism in the androgen receptor gene is associated with HDL-cholesterol but not with coronary atherosclerosis or myocardial infarction. Clin Chem 2005;51:1110-1115. (Pubitemid 43079386)
28. Diamanti-Kandarakis E, Mitrakou A, Raptis S, Tolis G, Duleba AJ. The effect of a pure antiandrogen receptor blocker, flutamiDe, on the lipid profile in the polycystic ovary syndrome. J Clin Endocrinol. Metab. 1998;83:2699-2705. (Pubitemid 28493763)
29. Rebuffe-Scrive M, Marin P, Bjorntorp P. Effect of testosterone on abdominal adipose tissue in men. Int J Obes 1991;15:791-795.
30. Yeh S, Chang C. Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells. Proc Natl Acad Sci USA 1996;93:5517-5521.